Telehealth treatment for opioid use disorder delivered at home
Ophelia is a New York-based telehealth provider offering at-home, medication-based treatment for opioid use disorder. Its hiring is clinically weighted with a sales layer focused on referral networks and partnerships, and a modern data stack (RudderStack, BigQuery, dbt, Lightdash) points to a metrics-driven growth engine tracking patient enrollment across state expansion.
Ophelia, founded in 2020 and headquartered in New York, provides virtual care for people with opioid use disorder, including medications for opioid use disorder (MOUD) delivered remotely. The privately held company employs 51–200 people and hires within the United States. Its workforce spans clinical healthcare staff, sales, operations, product and support. Growth runs through paid digital channels, peer-led outreach, referral partners and B2B integrations, supported by Salesforce, HubSpot and Customer.io for CRM and patient engagement.
Ophelia uses TypeScript, React, Firebase and Firestore on GCP, with RudderStack, BigQuery, dbt and Lightdash for data, plus Salesforce, HubSpot and Customer.io for CRM and messaging.
Yes, hiring is accelerating in the United States, led by healthcare and clinical roles, with additional openings in sales, operations, product and support.
Ophelia is focused on paid digital and peer-led growth, new partnership acquisition, B2B integrations, CRM data management, dashboards and patient enrollment tracking.
Other companies in the same industry, closest in size
Ophelia's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.
